About us

Coremine Vitae is a patient-centered biomedical company. Our wish is to give everyone the opportunity to receive personalized medicine by producing evidence-based information about the best treatment options based on the patient's profile and biomarkers.

Coremine Vitae has a broad scientific background with "state of the art" knowledge in molecular biology, biomedicine, oncology and medicine. Most of the people in our analysis team have a PhD and extensive experience from research and clinical patient care.

We have participated and are participating in a number of research projects in collaboration with leading medical environments in Norway and Europe.

The Coremine Vitae team collaborates with PubGene AS in the research project "Coremine Vitae - to identify personalized treatment options for cancer patients" where Haukeland University Hospital and Sykehuset Innlandet are partners. The research project has support from the Research Council of Norway and includes both the development of analysis tools and the implementation of Coremine Vitae analyzes for patients in order to generate information about relevant treatments.

We work closely with PubGene AS and Vitae Evidence AS, which provide complementary knowledge in bioinformatics and tool support for our medical analysts.


Maria Mastrangelopoulou
Science Team
Leader of Scientific Team
PhD in medicine from University of Oslo​Expertise in the field of Neuroscience and Neuro-oncology
Kathleen Heck
Science Team
Coremine Vitae Analyst
MSc. In Molecular Medicine from Trinity College, Dublin​Experience with clinical diagnostics, In-Vitro Diagnostics and cancer research
Pegah Abdollahi
Science Team
Coremine Vitae Analyst
PhD in cancer research and Molecular medicine ​Expertise in cancer biology and tumor immunology
John Stacy
Science Team
Coremine Vitae Analyst
PhD in Genetics from the University of Oslo
Arne Færden
Science Team
Medical advisor
General Surgeon and Gastrointestinal Surgeon​Head of Colorectal Unit at AHUS between 2001 and 2015​PhD from the University of Oslo
Frida Næss-Ulseth
Management Team
MSc Industrial Economics and Technology Management at NTNU​Former cancer patient
Martine Retting
Management Team
Master in Political Science from NTNU and UiO. Responsible for the operational strategy and implementation
Jorun Ruud
Management Team
Chairman of the Board
MSc Marketing ScienceOver 25 years of experience in business- and product development and managemen
Vanessa Brito Canzonieri
Marketing and Sales
UX and Marketing
Background in engineering from Venezuela. ​User research and product development


Marit Inngjerdingen​
Professor at the Department of Pharmacology, Department of Clinical Medicine, University of Oslo​Leads the research group "Congenital lymphocytes and cancer"​Founder and managing director of the company Cellmover, which develops peptides for cellular immunotherapy.
Mark Tyrrell
Doctor and Medical Advisor​Over 13 years experience as a GP in England​Medical Director and General Manager of Vitae Evidence​
Tor Kristian Jenssen​
Founded PubGene while completing his PhD.Over 20 years of experience in bioinformatics, text mining and informatics for precision therapies. ​Tor Kristian combines a technical background with supporting clinical decisions and QA for the Coremine Vitae analysts.
Anne-Lise Børresen Dale
PhD in medicine from University of Oslo​Expertise in the field of Neuroscience and Neuro-oncology
Bjarte Reve
Partner Development
Over 20 years of experience from private and public healthcare​. Former Chief Communications Officer at Akershus University Hospital (AHUS) ​Developed Helseinnovatørskolen together with UiO, NTNU and Karolinska Institutet
Coremine Vitae logoLogo
Coremine Vitae provides patient-precise reports about treatment options for cancer diagnosis and other life-altering diseases.
Coremine Vitae AS
Klaus Torgårds vei 3, 0372